Abzena and Telix sign licence agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies
Under the terms of the Agreement, Abzena has granted Telix an exclusive worldwide, royalty bearing, sub-licensable licence to its prostate-specific membrane antigen (‘PSMA’) antibodies in the field of radio-immunoconjugation. The PSMA antibodies were created using Abzena’s Composite Human Antibody™ technology.Read More
Technologies and Solutions
Abzena provides proprietary technologies and complementary solutions to organisations involved in the development of biopharmaceutical products.
Latest News and Events
Abzena presents its latest research and exhibits at events all over the world.
Find out where we are next and our latest news below.
Abzena announces appointment of Petra Dieterich as Scientific Lead
WEBINAR – ADC Developability for successful lead candidate selection
22 September 2021
Abzena Opens a New Biologics Testing Lab to Support Partners Programs
WADC London 2022
29 March 2022
Resources and Downloads
Find our latest videos, brochures and fact sheets in our resources section.
Download our Brochure
Technology & Solutions BrochureDownload File
Stability of Maleimide-PEG and Mono-Sulfone-PEG Conjugation to a Novel Engineered Cysteine in the Human Hemoglobin Alpha Subunit
In order to use a Hemoglobin Based Oxygen Carrier as an oxygen therapeutic or blood…Read More
Cell Line Development Lab Tour
Abzena has over 10 years experience in Cell Line Development for customers and has completed…